Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] traded at a low on 2025-06-26, posting a -53.12 loss after which it closed the day’ session at $686520.0.
The results of the trading session contributed to over 21283142 shares changing hands. Over the past one week, the price volatility of Reviva Pharmaceuticals Holdings Inc stands at 19.29% while the volatility over the past one month is 12.19%.
The market cap for RVPH stock reached $17.19 million, with 46.74 million shares outstanding and 41.78 million shares in the current float. Compared to the average trading volume of 686.52K shares, RVPH reached a trading volume of 21283142 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Reviva Pharmaceuticals Holdings Inc [RVPH]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVPH shares is $9.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVPH stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for Reviva Pharmaceuticals Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 20, 2023. While these analysts kept the previous recommendation, The Benchmark Company raised their target price to Speculative Buy. The new note on the price target was released on June 08, 2023, representing the official price target for Reviva Pharmaceuticals Holdings Inc stock. Previously, the target price had yet another raise to $10, while H.C. Wainwright analysts kept a Buy rating on RVPH stock.
How has RVPH stock performed recently?
Reviva Pharmaceuticals Holdings Inc [RVPH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -46.88. With this latest performance, RVPH shares dropped by -67.45% in over the last four-week period, additionally sinking by -73.28% over the last 6 months – not to mention a drop of -80.22% in the past year of trading.
Reviva Pharmaceuticals Holdings Inc [RVPH]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -281.12%, with Return on Assets sitting at -281.12%.
Earnings analysis for Reviva Pharmaceuticals Holdings Inc [RVPH]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RVPH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Reviva Pharmaceuticals Holdings Inc go to 22.32%.
Insider trade positions for Reviva Pharmaceuticals Holdings Inc [RVPH]
The top three institutional holders of RVPH stocks are: WOODLINE PARTNERS LP with ownership of 1.59 million shares, which is approximately 5.2129%. MILLENNIUM MANAGEMENT LLC, holding 1.24 million shares of the stock with an approximate value of $$1.59 million in RVPH stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $$1.31 million in RVPH stock with ownership which is approximately 3.3554%.
